XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Scheddule Of Effect Of Restatement On Previously Reported Amounts In Balance Sheet (Details) (USD $)
Sep. 30, 2012
Sep. 30, 2011
May 10, 2011
Sep. 30, 2010
Sep. 30, 2009
Sep. 30, 2008
Sep. 30, 2007
Sep. 13, 2007
Cash    $ 5,222   $ 3,882         
Website property, net of accumulated amortization    350,000            
Total Assets    355,222            
Current Liabilities                
Accounts payable 18,862 18,228            
Accounts payable, related party 20,270 25,270            
Accrued expenses 134,266 8,824            
Accrued officer compensation 347,976 218,450            
Advances from officers 9,127 7,837            
Due to a related party 2,960 790            
Derivative liability 468,884 116,504            
Convertible debentures , net of discount 759,073 309,002            
Total Liabilities 1,761,420 704,905            
Stockholders' Equity (Deficit)                
Common stock , $.0001 par value, 485,000,000 shares authorized, 24,570,991 and 24,120,991 issued and outstanding, respectively 2,929 2,412            
Additional paid in capital 3,306,110 2,826,660            
Common stock subscribed 751,650 779,000            
Stock subscription receivable     (8,025)          
Deficit accumulated during development stage (5,839,472) (3,957,755)            
Total Stockholders Equity (Deficit) (1,761,420) (349,683)   3,592 (282) 3,029 500   
Total Liabilities and Stockholders Equity (Deficit)    355,222            
As Reported
               
Cash   5,222            
Website property, net of accumulated amortization   350,000            
Total Assets   355,222            
Current Liabilities                
Accounts payable   20,228            
Accounts payable, related party   23,270            
Accrued expenses   8,822            
Accrued officer compensation   218,450            
Advances from officers   7,837            
Due to a related party   790            
Derivative liability                 
Convertible debentures , net of discount   88,225            
Total Liabilities   367,622            
Stockholders' Equity (Deficit)                
Common stock , $.0001 par value, 485,000,000 shares authorized, 24,570,991 and 24,120,991 issued and outstanding, respectively   2,412            
Additional paid in capital   3,191,660            
Common stock subscribed   779,000            
Stock subscription receivable   (70,365)            
Deficit accumulated during development stage   (3,915,107)            
Total Stockholders Equity (Deficit)   (12,400)            
Total Liabilities and Stockholders Equity (Deficit)   355,222            
Adjustment
               
Cash                 
Website property, net of accumulated amortization                 
Total Assets                 
Current Liabilities                
Accounts payable                 
Accounts payable, related party                 
Accrued expenses   2            
Accrued officer compensation                 
Advances from officers                 
Due to a related party                 
Derivative liability   116,504            
Convertible debentures , net of discount   220,777            
Total Liabilities   337,283            
Stockholders' Equity (Deficit)                
Common stock , $.0001 par value, 485,000,000 shares authorized, 24,570,991 and 24,120,991 issued and outstanding, respectively                 
Additional paid in capital   (365,000)            
Common stock subscribed                 
Stock subscription receivable   70,365            
Deficit accumulated during development stage   (42,648)            
Total Stockholders Equity (Deficit)   (337,283)            
Total Liabilities and Stockholders Equity (Deficit)                 
As Restated
               
Cash   5,222            
Website property, net of accumulated amortization   350,000            
Total Assets   355,222            
Current Liabilities                
Accounts payable   20,228            
Accounts payable, related party   23,270            
Accrued expenses   8,824            
Accrued officer compensation   218,450            
Advances from officers   7,837            
Due to a related party   790            
Derivative liability   116,504            
Convertible debentures , net of discount   309,002            
Total Liabilities   704,905            
Stockholders' Equity (Deficit)                
Common stock , $.0001 par value, 485,000,000 shares authorized, 24,570,991 and 24,120,991 issued and outstanding, respectively   2,412            
Additional paid in capital   2,826,660            
Common stock subscribed   779,000            
Stock subscription receivable                 
Deficit accumulated during development stage   (3,957,755)            
Total Stockholders Equity (Deficit)   (349,683)            
Total Liabilities and Stockholders Equity (Deficit)   $ 355,222